Diligence memo · auto-generated · as of July 2, 2026
Titan Partners, Llc
Titan Partners, Llc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Titan Partners, Llc operates in Pharmaceuticals, based in DALLAS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Titan Partners, Llc has raised $498K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $250K on 2013-12-16.
Most recent recorded round closed around 2015-02-25.
Valuation (modeled)modeled
Provath models Titan Partners, Llc at approximately $12M (range $139K–$133M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.03× the median modeled value of Pre-Seed Pharmaceuticals companies in 2013–2015 (87 peers) — value vs value, same stage and era. Within the normal band (103% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 14 months.
Last raise 11.3 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 11% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 19% of those peers.
Closest niche peers: IPM Safety Services, Inc., Scioderm, LLC, Chondrial Therapeutics, LLC, OnCore Biopharma, Inc., VR1 Corp.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.